Teleflex

The latest read

Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 30, 2026: $2.25 billion, up 110% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $0.17 billion.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to June 30, 2026: $0.08 billion.SEC EDGAR filings (XBRL)
• Share buybacks in the fiscal year to December 31, 2025: $0.30 billion.SEC EDGAR filings (10-K)
• Long-term debt issued in the fiscal year to December 31, 2025: $1.14 billion.SEC EDGAR filings (10-K)
• Latest earnings call or results release (August 6, 2026): sentiment -0.20 on a −1 to +1 scale (negative), confidence 0.60 of 1.Palanor Discourse
• Guidance in the last 90 days: 1 outlook figure raised, 3 lowered, 0 held.Guidance Ledger (8-K results releases)
• Latest annual report (filed February 27, 2026): 1 risk factor added, 1 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net buyers in Q3 2025: $0.6 million on the open market.SEC Form 4
• 383 institutional managers reported a position at June 30, 2026 (+17 on the quarter before).SEC Form 13F
• H-1B filings certified in Q2 2026: 8 (9 a year earlier).U.S. Department of Labor (OFLC)

Risk events (12 months): 1 — latest OSHA inspection, Mar 31, 2026 →

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for Teleflex yet.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Oct 20, 2026Lobbying
   Lobbying report (LIBERTY PARTNERS GROUP, LLC)third_quarter 2026
2. Oct 19, 2026Lobbying
   Lobbying report (ARNOLD & PORTER KAYE SCHOLER LLP)third_quarter 2026 · $0.1 million
3. Oct 13, 2026Patent
   Patent granted: MEDICAL KIT PACKAGE AND PRODUCT MARRYING PROCESSUS 12759779
4. Oct 13, 2026Patent
   Patent granted: CATHETER SYSTEM FOR IMPLANTING A MEDICAL IMPLANT TO FORM A MEDICAL BYPASS CONNECTIONUS 12758223
5. Oct 13, 2026Patent
   Patent granted: BONE-PENETRATING INTRAOSSEOUS ACCESS DEVICEUS 12758260
6. Oct 8, 2026Lobbying
   Lobbying report (CORNERSTONE GOVERNMENT AFFAIRS, INC.)third_quarter 2026 · $0.0 million
7. Oct 6, 2026Patent
   Patent granted: TISSUE MONITORING ELECTROSURGICAL INSTRUMENTS AND METHODS OF USING THE SAMEUS 12751761
8. Oct 6, 2026Patent
   Patent granted: ELUTING PERFUSION CATHETERS AND RELATED METHODSUS 12752087
9. Sep 9, 20268-K
   Director or officer changeItem 5.02
10. Aug 3, 20268-K
    Acquisition or sale completedItem 2.01
11. Jul 21, 2026Lobbying
    Lobbying report (LIBERTY PARTNERS GROUP, LLC)second_quarter 2026
12. Jul 21, 2026Lobbying
    Lobbying report (LIBERTY PARTNERS GROUP, LLC)second_quarter 2026
13. Jul 20, 2026Lobbying
    Lobbying report (ARNOLD & PORTER KAYE SCHOLER LLP)second_quarter 2026 · $0.0 million
14. Jul 13, 2026Lobbying
    Lobbying report (CORNERSTONE GOVERNMENT AFFAIRS, INC.)second_quarter 2026 · $0.0 million
15. Jun 15, 20268-K
    Material agreement signedItem 1.01
16. Jun 9, 20268-K
    Director or officer changeItem 5.02
17. May 27, 20268-K
    Material agreement signedItem 1.01
18. May 20, 20268-K
    Shareholder vote resultsItem 5.07
19. Apr 30, 20268-K
    Director or officer changeItem 5.02
20. Apr 20, 2026Lobbying
    Lobbying report (ARNOLD & PORTER KAYE SCHOLER LLP)first_quarter 2026 · $0.1 million
21. Mar 31, 2026Risk event
    OSHA complaint inspection: TELEFLEX INCOSHA
22. Feb 27, 202610-K
    Annual report (10-K)1 risk factors added, 1 removed
23. Feb 26, 20268-K
    Exit or restructuring costsItem 2.05
24. Jan 23, 20268-K
    Director or officer changeItem 5.02
25. Jan 8, 20268-K
    Director or officer changeItem 5.02
26. Dec 9, 20258-K
    Material agreement signedItem 1.01
27. Dec 9, 2025Trademark
    Trademark application
28. Sep 16, 2025Trademark
    Trademark application
29. Jun 30, 20258-K
    Material agreement signedItem 1.01
30. May 15, 20258-K
    Shareholder vote resultsItem 5.07
31. Feb 28, 202510-K
    Annual report (10-K)3 risk factors added, 0 removed
32. Feb 27, 20258-K
    Material agreement signedItem 1.01
33. Feb 27, 20258-K
    Director or officer changeItem 5.02
34. Feb 23, 202410-K
    Annual report (10-K)0 risk factors added, 0 removed

Peers

Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

96943

LEI

UUL85LWXB4NGSWWXIQ25

Wikidata

Q7696143